1. What is the Chemxpert database?

Chemxpert database is a techno-commercial information platform developed and operated by Lifescience Intellipedia Pvt. Ltd. Our data provides valuable insights regarding sourcing, marketing, development, and regulatory functions for the entire Lifescience industry. The different industries covered by our data encompass APIs, FDFs, pharma intermediates, paints, dyes, polymers, biotechnology, biochemical, food additives, nutraceuticals, etc.

2. How can I subscribe to the Chemxpert database?

You can gain access to the Chemxpert database after subscribing to it by visiting this link: - https://chemxpert.com/pricing

3. How many countries' data is available on your portal?

The Chemxpert database covers more than 200 countries. We are working in the direction of expanding our data coverage in more countries.

4. What are the different sources you use for obtaining information?

The different sources we use for data collection are as follows: - • Primary researc • DMF, ANDA, & CEP list • Conferences, Exhibitions, & Tradeshow • Company annual reports • DMF, ANDA, & CEP list • Subject matter experts & KOL survey. Apart from these, our other valuable sources include application-wise manufacturers list, subscribed and non-subscribed databases, corporate partners, US FDA Orange book, publicly available sources, industry associates, national statistics, regulatory websites, etc. You can gain access to the Chemxpert database after subscribing to it by visiting this link: -https://chemxpert.com/sources

5. What is the expected time for account activation?

Your Chemxpert account will be activated instantly if the payment is made through our website. If you choose to use RTGS, NEFT, or IMPS systems for payment, your account will be activated within 24 hours.

23 Dec 2020
Admin
News Article

Strides Gets Usfda Nod For Generic Oxybutynin Chloride Tablets

Drug Firm Strides Pharma Science On Friday Said Its Singapore-Based Arm Has Received Approval From The Us Health Regulator For Generic Oxybutynin Chloride Tablets Used To Treat Symptoms Of Overactive Bladder And Urinary Incontinence.Company'S Step-Down Wholly Owned Subsidiary Strides Pharma Global Pte Ltd, Singapore, Has Received Approval For Oxybutynin Chloride Tablets Usp, 5 Mg From The United States Food &Amp; Drug Administration (Usfda), Strides Said In A Filing To Bse.The Product Is A Generic Version Of Janssen Pharmaceuticals Inc'S Ditropan Tablets In The Same Strength, It Added. The Product Will Be Manufactured At The Company'S Flagship Facility At Bengaluru And Will Be Marketed By Strides Pharma Inc In The Us Market, Strides Said."According To Iqvia Mat October 2020 Data, The Us Market For Oxybutynin Chloride Tablets Usp, 5 Mg Is Approximately Usd 29 Million", It Added.The Company Has 127 Cumulative Abbreviated New Drug Application (Anda) Filings With Usfda Of Which 94 Andas Have Been Approved And 33 Are Pending Approval, The Filing Said.Shares Of Strides Pharma Science Were Trading At Rs 785.75 Per Scrip On Bse, Up 1.90 Per Cent From Its Previous Close.

Let’s apply Data-Driven Pricing to Your APIs

Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.

Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.

Start using market intelligence today and allow yourself to be in control in the API market.

Check it out today and make more informed sourcing decisions! Learn More!